Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)

References

• GiblettERAndersonJECohenFPollaraBMeuwissenHJAdenosine-deaminase deficiency in two patients with severely impaired cellular immunityLancet197227786106710694117384
   PubMed Web of Science ®Google Scholar
• HershfieldMMitchellBSScriverCRBeaudetALSlyWSValleDImmunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiencyThe Metabolic and Molecular Basis of Inherited DiseaseNew YorkMcGraw-Hill200125852625
   Google Scholar
• HirschhornROverview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiencyPediatr Res1993331 SupplS35S418433873
   PubMed Web of Science ®Google Scholar
• LainkaEHershfieldMSSantistebanIpolyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiencyClin Diagn Lab Immunol200512786186616002636
   PubMedGoogle Scholar
• LeeNRussellNGaneshaguruKMechanisms of deoxy -adenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminaseBr J Haematol19845611071196231047
   PubMed Web of Science ®Google Scholar
• Gangi-PetersonLSorscherDHReynoldsJWKeplerTBMitchellBSNucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombinationJ Clin Invest1999103683384110079104
   PubMed Web of Science ®Google Scholar
• HirschhornRMartiniukFRosenFSAdenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiencyClin Immunol Immunopathol197893287292627115
   PubMedGoogle Scholar
• RogersMHLwinRFairbanksLGerritsenBGasparHBCognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiencyJ Pediatr20011391445011445793
   PubMed Web of Science ®Google Scholar
• RatechHGrecoMAGalloGPathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterationsAm J Pathol198512011571694014441
   PubMed Web of Science ®Google Scholar
• HershfieldMSSteimEROchsHDWinkelsteinJACombined immune deficiencies due to purine enzyme defectsImmunologic Disorders in Infants and ChildrenPhiladelphiaWB Saunders2004480504
   Google Scholar
• NotarangeloLDStoppoloniGToraldoRInsulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiencyEur J Pediatr1992151118118141468454
   PubMed Web of Science ®Google Scholar
• BollingerMErredondo-VegaFXSantistebanIBrief report: hepatic dysfunction as a complication of adenosine deaminase deficiencyN Engl J Med199633421136713718614422
   PubMed Web of Science ®Google Scholar
• HirschhornRPuckJMImmunodeficiency disease due to deficiency of adenosine deaminasePrimary Immunodeficiency Diseases: A Molecular and Genetic ApproachNew York, NYOxford1999121139
   Google Scholar
• PetersenMBTranebjaergLTommerupNNygaardPEdwardsHNew assignment of the adenosine deaminase gene locus to chromosome 20q13 × 11 by study of a patient with interstitial deletion 20qJ Med Genet198724293963560174
   PubMed Web of Science ®Google Scholar
• DooleyTFairbanksLDSimmondsHAFirst trimester diagnosis of adenosine deaminase deficiencyPrenat Diagn1987785615653120171
   PubMed Web of Science ®Google Scholar
• BoothCHershfieldMNotarangeloLManagement options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)Clin Immunol2007123213914717300989
   PubMed Web of Science ®Google Scholar
• AiutiACattaneoFGalimbertiSGene therapy for immuno-deficiency due to adenosine deaminase deficiencyN Engl J Med2009360544745819179314
   PubMed Web of Science ®Google Scholar
• GasparHBBjorkegrenEParsleyKSuccessful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioningMol Ther200614450551316905365
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-AbinaSGarrigueAWangGPInsertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1J Clin Invest200811893132314218688285
   PubMed Web of Science ®Google Scholar
• OttMGSchmidtMSchwarzwaelderKCorrection of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Nat Med200612440140916582916
   PubMed Web of Science ®Google Scholar
• PolmarSHWetzlerEMSternRCHirschhornRRestoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiencyLancet19752793874374652774
   PubMed Web of Science ®Google Scholar
• PolmarSHSternRCSchwartzALEnzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiencyN Engl J Med19762952413371343980079
   PubMed Web of Science ®Google Scholar
• DyminskiJWDaoudALampkinBCImmunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency diseaseClin Immunol Immunopathol1979143307326498598
   PubMedGoogle Scholar
• HirschhornRPaageorgiouPSKesarwalaHHTaftLTAmerioration of neurologic abnormalities after “enzyme replacement” in adenosine deaminase deficiencyN Engl J Med198030373773806156414
   PubMed Web of Science ®Google Scholar
• HuttonJJWigintonDAColemanMSBiochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapyJ Clin Invest19816824134217263861
   PubMed Web of Science ®Google Scholar
• BaxBEBainMDFairbanksLDA 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiencyEur J Haematol200779433834817680812
   PubMed Web of Science ®Google Scholar
• BoryCBoulieuRSouilletGComparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child: measurement of erythrocyte deoxyadenosine triphosphate as a useful toolPediatr Res19902821271302395602
   PubMed Web of Science ®Google Scholar
• AbuchowskiAMcCoyJRPalczukNCVanETDavisFFEffect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalaseJ Biol Chem1977252113582358616907
   PubMed Web of Science ®Google Scholar
• DavisSAbuchowskiAParkYKDavisFFAlteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycolClin Exp Immunol1981466496527337981
   PubMed Web of Science ®Google Scholar
• HershfieldMSBuckleyRHGreenbergMLTreatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminaseN Engl J Med1987316105895963807953
   PubMed Web of Science ®Google Scholar
• WeinbergKHershfieldMSBastianJT lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminaseJ Clin Invest19939225966028349799
   PubMed Web of Science ®Google Scholar
• HershfieldMSChaffeeSSorensenRUEnzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapyPediatr Res1993331 SupplS42S478433874
   PubMed Web of Science ®Google Scholar
• HershfieldMSPEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 yearsClin Immunol Immunopathol1995763 Pt 2S228S2327554473
   PubMedGoogle Scholar
• OchsHDBuckleyRHKobayashiRHAntibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiencyBlood1992805116311711387561
   PubMed Web of Science ®Google Scholar
• LevyYHershfieldMSFernandez-MejiaCAdenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminaseJ Pediatr198811323123173260944
   PubMed Web of Science ®Google Scholar
• MalacarneFBenicchiTNotarangeloLDReduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patientsEur J Immunol200535113376338616276484
   PubMed Web of Science ®Google Scholar
• ChanBWaraDBastianJLong-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)Clin Immunol2005117213314316112907
   PubMed Web of Science ®Google Scholar
• ThompsonLFVan de WieleCJLaurentABMetabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ culturesJ Clin Invest200010691149115711067867
   PubMed Web of Science ®Google Scholar
• HusainMGrunebaumENaqviABurkitt’s lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminaseJ Pediatr20071511939517586199
   PubMed Web of Science ®Google Scholar
• KaufmanDAHershfieldMSBocchiniJACerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminasePediatrics20051166e876e87916263974
   PubMed Web of Science ®Google Scholar
• BlackburnMRVolmerJBThrasherJLMetabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstructionJ Exp Med2000192215917010899903
   PubMed Web of Science ®Google Scholar
• BlackburnMRAldrichMVolmerJBThe use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalitiesJ Biol Chem200027541321143212110908569
   PubMed Web of Science ®Google Scholar
• MarwahaVRItaliaDHEsperFHostofferRWExtreme thrombocytosis in response to PEG-ADA: early therapeutic and risk indicatorClin Pediatr (Phila)200039318318610752014
   PubMed Web of Science ®Google Scholar
• ChaffeeSMaryAStiehmERIgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiencyJ Clin Invest1992895164316511569204
   PubMed Web of Science ®Google Scholar
• BlaeseRMCulverKWMillerADT lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 yearsScience199527052354754807570001
   PubMed Web of Science ®Google Scholar
• AiutiAGene therapy for adenosine-deaminase-deficient severe combined immunodeficiencyBest Pract Res Clin Haematol200417350551615498720
   PubMed Web of Science ®Google Scholar